or Try an Advanced Search...

    Technical Analysis for MIRA - MIRA Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.76 -0.01% 0.00
    MIRA closed down 0.01 percent on Wednesday, May 8, 2024, on 1 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical MIRA trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Bollinger Band Squeeze Range Contraction -0.01%
    Wide Bands Range Expansion -0.01%
    Oversold Stochastic Weakness -0.01%
    Jack-in-the-Box Bearish Bearish Swing Setup 1.32%
    Bollinger Band Squeeze Range Contraction 1.32%
    Stochastic Reached Oversold Weakness 1.32%
    Older End-of-Day Signals for MIRA ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 11 hours ago
    Gap Up Closed about 13 hours ago
    Reversed from Up about 13 hours ago
    Gapped Up (Full) about 14 hours ago
    Rose Above Previous Day's High about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MIRA Chart by TradingView
    Basic chart:

    Profile

    MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog for treating anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - General
    Keywords: Cannabis Euphoriants Chronic Pain Entheogens Cannabinoid Antiemetics Ajulemic Acid Appetite Stimulants

    Is MIRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 2 MIRA Making Strides Toward Breakthrough Treatment
    Apr 2 Mira Pharmaceuticals Announces Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
    Mar 21 MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
    Feb 6 Is MIRA Pharmaceuticals (NASDAQ:MIRA) In A Good Position To Deliver On Growth Plans?
    Feb 5 MIRA Pharmaceuticals Provides Corporate Update
    Jan 29 IPO Roundup: Amer Sports, FibroBiologics, and more
    Dec 18 MIRA Pharmaceuticals files to sell up to 1.7M shares for holders
    Nov 29 MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%
    Nov 27 MIRA Makes Great Deal for Potential Blockbuster
    Nov 21 MIRA Pharmaceuticals To Host Shareholder Update Call on Tuesday, December 5, 2023 at 11:30 a.m. Eastern Time
    See more MIRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.9799
    52 Week Low 0.72
    Average Volume 721,161
    200-Day Moving Average 0.00
    50-Day Moving Average 1.01
    20-Day Moving Average 0.83
    10-Day Moving Average 0.81
    Average True Range 0.08
    RSI (14) 33.77
    ADX 20.92
    +DI 12.25
    -DI 22.88
    Chandelier Exit (Long, 3 ATRs) 0.81
    Chandelier Exit (Short, 3 ATRs) 0.95
    Upper Bollinger Bands 0.95
    Lower Bollinger Band 0.72
    Percent B (%b) 0.18
    BandWidth 27.71
    MACD Line -0.07
    MACD Signal Line -0.07
    MACD Histogram -0.0016
    Fundamentals Value
    Market Cap 11.23 Million
    Num Shares 14.8 Million
    EPS -0.51
    Price-to-Earnings (P/E) Ratio -1.49
    Price-to-Sales 0.00
    Price-to-Book 1.93
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.88
    Resistance 3 (R3) 0.88 0.84 0.86
    Resistance 2 (R2) 0.84 0.81 0.84 0.85
    Resistance 1 (R1) 0.80 0.80 0.78 0.80 0.84
    Pivot Point 0.77 0.77 0.76 0.76 0.77
    Support 1 (S1) 0.72 0.74 0.71 0.72 0.68
    Support 2 (S2) 0.69 0.72 0.69 0.67
    Support 3 (S3) 0.65 0.69 0.66
    Support 4 (S4) 0.64